https://stock.noler.com/us/stock/hookipa-pharma-inc https://stock.noler.com/us/stock/hookipa-pharma-inc/accounts-payable https://stock.noler.com/us/stock/hookipa-pharma-inc/accounts-receivable https://stock.noler.com/us/stock/hookipa-pharma-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/hookipa-pharma-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/hookipa-pharma-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/hookipa-pharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/hookipa-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/hookipa-pharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/hookipa-pharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/aoci https://stock.noler.com/us/stock/hookipa-pharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/hookipa-pharma-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/hookipa-pharma-inc/assets-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/basic-shares https://stock.noler.com/us/stock/hookipa-pharma-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/hookipa-pharma-inc/capital-expenditures https://stock.noler.com/us/stock/hookipa-pharma-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/hookipa-pharma-inc/capitalized-computer-software-amortization https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/hookipa-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/hookipa-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/hookipa-pharma-inc/common-stock-value https://stock.noler.com/us/stock/hookipa-pharma-inc/comprehensive-income https://stock.noler.com/us/stock/hookipa-pharma-inc/contract-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/contractual-obligation https://stock.noler.com/us/stock/hookipa-pharma-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/hookipa-pharma-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/hookipa-pharma-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/hookipa-pharma-inc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/hookipa-pharma-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/hookipa-pharma-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/hookipa-pharma-inc/costs-and-expenses https://stock.noler.com/us/stock/hookipa-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/hookipa-pharma-inc/current-assets https://stock.noler.com/us/stock/hookipa-pharma-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/hookipa-pharma-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/hookipa-pharma-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/hookipa-pharma-inc/current-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-unamortized-discount https://stock.noler.com/us/stock/hookipa-pharma-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-offering-costs https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-revenue https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/hookipa-pharma-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/hookipa-pharma-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/hookipa-pharma-inc/depreciation https://stock.noler.com/us/stock/hookipa-pharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/hookipa-pharma-inc/diluted-shares https://stock.noler.com/us/stock/hookipa-pharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/hookipa-pharma-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/hookipa-pharma-inc/effective-tax-rate https://stock.noler.com/us/stock/hookipa-pharma-inc/eps https://stock.noler.com/us/stock/hookipa-pharma-inc/eps-basic https://stock.noler.com/us/stock/hookipa-pharma-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/hookipa-pharma-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-current https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/hookipa-pharma-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/hookipa-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/hookipa-pharma-inc/foreign-pretax-income https://stock.noler.com/us/stock/hookipa-pharma-inc/form-d-stocks https://stock.noler.com/us/stock/hookipa-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/hosting-arrangement-service-contract-implementation-cost-expense-amortization https://stock.noler.com/us/stock/hookipa-pharma-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/hookipa-pharma-inc/income-tax https://stock.noler.com/us/stock/hookipa-pharma-inc/income-taxes-paid https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/hookipa-pharma-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/hookipa-pharma-inc/insider-transactions-other https://stock.noler.com/us/stock/hookipa-pharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/hookipa-pharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/hookipa-pharma-inc/interest-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/hookipa-pharma-inc/interest-expense-on-debt https://stock.noler.com/us/stock/hookipa-pharma-inc/interest-paid https://stock.noler.com/us/stock/hookipa-pharma-inc/interest-paid-net https://stock.noler.com/us/stock/hookipa-pharma-inc/investing-cash-flow https://stock.noler.com/us/stock/hookipa-pharma-inc/investment-income-interest https://stock.noler.com/us/stock/hookipa-pharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/lease-cost https://stock.noler.com/us/stock/hookipa-pharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/hookipa-pharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/hookipa-pharma-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/hookipa-pharma-inc/liabilities-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/loans-payable https://stock.noler.com/us/stock/hookipa-pharma-inc/loans-payable-current https://stock.noler.com/us/stock/hookipa-pharma-inc/long-term-loans-payable https://stock.noler.com/us/stock/hookipa-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/hookipa-pharma-inc/net-income https://stock.noler.com/us/stock/hookipa-pharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/hookipa-pharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-expenses https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-income https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-assets https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/hookipa-pharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/hookipa-pharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/hookipa-pharma-inc/other-income https://stock.noler.com/us/stock/hookipa-pharma-inc/other-noncash-income-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/hookipa-pharma-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/hookipa-pharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/hookipa-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/hookipa-pharma-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/hookipa-pharma-inc/payments-for-restructuring https://stock.noler.com/us/stock/hookipa-pharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/hookipa-pharma-inc/preferred-stock-value https://stock.noler.com/us/stock/hookipa-pharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/hookipa-pharma-inc/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/pretax-income https://stock.noler.com/us/stock/hookipa-pharma-inc/pretax-income-domestic https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/hookipa-pharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/hookipa-pharma-inc/profit-loss https://stock.noler.com/us/stock/hookipa-pharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/hookipa-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/hookipa-pharma-inc/public-float https://stock.noler.com/us/stock/hookipa-pharma-inc/repayments-of-debt https://stock.noler.com/us/stock/hookipa-pharma-inc/research-and-development https://stock.noler.com/us/stock/hookipa-pharma-inc/restricted-cash https://stock.noler.com/us/stock/hookipa-pharma-inc/restricted-cash-current https://stock.noler.com/us/stock/hookipa-pharma-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/hookipa-pharma-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/hookipa-pharma-inc/restructuring-charges https://stock.noler.com/us/stock/hookipa-pharma-inc/restructuring-reserve https://stock.noler.com/us/stock/hookipa-pharma-inc/retained-earnings https://stock.noler.com/us/stock/hookipa-pharma-inc/revenue https://stock.noler.com/us/stock/hookipa-pharma-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/hookipa-pharma-inc/severance-costs https://stock.noler.com/us/stock/hookipa-pharma-inc/share-price https://stock.noler.com/us/stock/hookipa-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/hookipa-pharma-inc/shares-authorized https://stock.noler.com/us/stock/hookipa-pharma-inc/shares-issued https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-options-other-share-increase-decrease-in-period-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/hookipa-pharma-inc/stock-split-ratio https://stock.noler.com/us/stock/hookipa-pharma-inc/sublease-income https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-gilti-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-gilti-percent https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/hookipa-pharma-inc/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-elimination-as-partof-reorganization https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/hookipa-pharma-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/hookipa-pharma-inc/total-assets https://stock.noler.com/us/stock/hookipa-pharma-inc/total-liabilities https://stock.noler.com/us/stock/hookipa-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/hookipa-pharma-inc/total-long-term-debt https://stock.noler.com/us/stock/hookipa-pharma-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/hookipa-pharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/hookipa-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted